| SPECIAL FEATURE |
|
| Year : 2011 | Volume
: 21
| Issue : 3 | Page : 143-151 |
Indian commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of chronic kidney disease-mineral and bone disorders
V Jha1, V Kher2, R Pisharody3, RK Sharma4, G Abraham5, Gokulnath6, A Almeida7, A Gupta4
1 Postgraduate Institute of Medical Education and Research, Chandigarh, India
2 Medanta Kidney and Urology Institute, Gurgaon, India
3 Medical College, Trivandrum, India
4 Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India
5 Sri Ramachandra Medical College and Research Institute, Chennai, India
6 St Johns Medical College Hospital, Bangalore, India
7 PD Hinduja National Hospital and Medical Research Centre, Mumbai, India
Correspondence Address:
V Jha
Postgraduate Institute of Medical Education and Research, Chandigarh 160 012
India
 Source of Support: The Workgroup gratefully acknowledges the support of Panacea Biotec, Conflict of Interest: None  | Check |
PMID: 21886971 
This commentary presents the view of an Expert Group of Indian nephrologists on adaptation and implementation of the Kidney Disease: Improving Global Outcomes (KDIGO) guidelines for evaluation and management of mineral and bone disorder in chronic kidney disease (CKD-MBD) for practice in India. Zonal meetings of nephrologists drawn from the cross-section were convened to discuss the KDIGO guidelines. Recommendations were presented in a central meeting of zonal representatives. The finalized recommendations were reviewed by all the participants. There was a broad agreement on most of the recommendations made by the KDIGO workgroup. Significant departures in the current guidelines from the previous Kidney Disease Outcome Quality Initiative (KDOQI) guidelines were also noted. The participants agreed that the available evidence did not allow more precise recommendations, and the recommended best practice suggestions were often based on relatively weak evidence. There is a remarkable lack of data from Indian patients. We comment on specific areas and amplify certain concepts where we feel that further guidance that goes beyond what is stated in the document might help Indian nephrologists in appropriate implementation of the KDIGO guidelines. This commentary is intended to help define practically implementable best practices based on current disease concepts and available research evidence, thereby positively affecting the quality of management of CKD-MBD in India, and eventually improving patient outcomes.
[FULL TEXT] [PDF]*
|
|
Editorial Board
